A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors

The use of monoclonal antibodies (mAb) for the diagnosis and treatment of malignancies is acquiring an increasing clinical importance, thanks to their specificity, efficacy and relative easiness of use. However, in the context of Epstein-Barr virus (EBV)-related malignancies, only cancers of B-cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Turrini, Riccardo, Merlo, Anna, Martorelli, Debora, Faè, Damiana Antonia, Sommaggio, Roberta, Montagner, Isabella Monia, Barbieri, Vito, Marin, Oriano, Zanovello, Paola, Dolcetti, Riccardo, Rosato, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414862/
https://www.ncbi.nlm.nih.gov/pubmed/28507812
http://dx.doi.org/10.1080/2162402X.2017.1304338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414862/
https://www.ncbi.nlm.nih.gov/pubmed/28507812
http://dx.doi.org/10.1080/2162402X.2017.1304338

Ejemplares similares